SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001145549-08-000952
Filing Date
2008-05-27
Accepted
2008-05-27 16:37:24
Documents
1
Group Members
KING VIEW DEVELOPMENT INTERNATIONAL LIMITEDTB PARTNERS GP LIMITEDTB PARTNERS GP2, L.P.TRUSTBRIDGE PARTNERS II, L.P.

Document Format Files

Seq Description Document Type Size
1 SIMCERE PHARMACEUTICAL GROUP h02154sc13g.htm SC 13G 88494
  Complete submission text file 0001145549-08-000952.txt   90698
Mailing Address NO. 699-18 XUAN WU AVENUE XUAN WU DISTRICT NANJING, JIANGSU PRO F4 210042
Business Address NO. 699-18 XUAN WU AVENUE XUAN WU DISTRICT NANJING, JIANGSU PRO F4 210042 (86)-25-8556-6666
Simcere Pharmaceutical Group (Subject) CIK: 0001384360 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83690 | Film No.: 08861117
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 2701B, AZIA CENTER 1233 LUJIAZUI RING ROAD SHANGHAI F4 200120
Business Address 2701B, AZIA CENTER 1233 LUJIAZUI RING ROAD SHANGHAI F4 200120 8621-5877-5990
TB Partners GP LTD (Filed by) CIK: 0001436081 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G